pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Shimane University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Be at least 18 years old at the time of consent. 2) Written consent has been obtained from the individual to participate in the study. 3) (Pancreatic tumor group) A pathological diagnosis of pancreatic cancer (including class IV by cytology) has been obtained. 4) (Disease control group) A pathological diagnosis of cancer of the esophagus, stomach, or colon has been obtained, treatment under general anesthesia is planned, and abdominal MRI or abdominal contrast-enhanced CT has been performed. 5) (Control group) Patients were scheduled for treatment under general anesthesia for a benign disease and underwent abdominal MRI or contrast-enhanced CT.
Exclusion criteria
Exclusion criteria: 1) All molars are missing 2) (Pancreatic tumor group) Patients with malignant tumors other than the pancreas. 3) (Disease control group) (Control group) Has a history of pancreatic resection. 4) (Disease control group) (Control group) Abdominal MRI or abdominal contrast-enhanced CT indicates pancreatic tumor, chronic pancreatitis, or pancreatic cystic lesion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Composition of bacterial flora | — |
Countries
Japan
Contacts
Public ContactNobuhiko Fukuba
Shimane University Internal medicine II
Outcome results
None listed